Sequella is Drug Discovery in United States that focus on mycobacterium tuberculosis business. Founded in 1997. They cover business area such as developer, novel antibiotic, drug-resistant bacterial, fungal and parasitic infection, helicobacter pylori, Clostridium, nontuberculous mycobacteria, trypanosome, physician, global health threat.
1997
( 27 years old in 2024 )
Mycobacterium Tuberculosis
-
9610 Medical Center Drive
Suite 200
Rockville, MD 20850
United States
Private
developernovel antibioticdrug-resistant bacterial, fungal and parasitic infectionhelicobacter pyloriClostridiumnontuberculous mycobacteriatrypanosomephysicianglobal health threat
* We use standard office opening hours in near Sequella's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sequella is Drug Discovery business from United States that founded in 1997 (27 years old in 2024), Sequella business is focusing on Mycobacterium Tuberculosis.
Sequella headquarter office and corporate office address is located in 9610 Medical Center Drive Suite 200 Rockville, MD 20850 United States.
Sequella was founded in United States.
In 2024, Sequella is currently focus on mycobacterium tuberculosis sector.
Above is snippet of Google Trends for "mycobacterium tuberculosis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sequella, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
